Can Steroids Cause Yeast Infections?
The Mechanism: How Steroids Enable Fungal Overgrowth
Corticosteroids suppress the immune system’s inflammatory response—the same mechanism that makes them effective for conditions like asthma, COPD, rheumatoid arthritis, and inflammatory bowel disease. This immunosuppression, however, impairs the body’s ability to control commensal organisms like Candida albicans that normally coexist without causing disease.
Specifically, corticosteroids reduce neutrophil function, impair T-cell activity, and alter mucosal immunity. Candida exploits this immune gap to proliferate and invade tissue barriers, causing symptomatic infection.
Types of Yeast Infections Associated with Steroids
Oral Thrush (Oropharyngeal Candidiasis)
Oral thrush is the most common fungal complication of corticosteroid use, particularly with inhaled corticosteroids (ICS) used for asthma and COPD. When inhaled steroids are deposited in the oral cavity and throat rather than reaching the lungs, they suppress local immune defenses and create conditions for Candida overgrowth.
Symptoms include white, curd-like patches on the inner cheeks, tongue, and palate; soreness or burning; difficulty swallowing; and loss of taste. Studies indicate oral candidiasis occurs in 1–10% of patients using ICS, depending on dose and device type.
Vaginal Yeast Infections
Systemic corticosteroids (oral prednisone, prednisolone, dexamethasone) suppress systemic immune function and alter the vaginal microbiome, increasing susceptibility to vulvovaginal candidiasis. Women with diabetes—a condition also exacerbated by corticosteroids—face compounded risk.
Systemic Candidiasis
In severely immunocompromised patients receiving high-dose or prolonged systemic steroids (e.g., transplant recipients, ICU patients on stress-dose hydrocortisone), invasive candidiasis is a life-threatening concern. This occurs when Candida enters the bloodstream (candidemia) and spreads to organs. This risk is rare in otherwise healthy individuals on short-course steroid therapy.
Risk Factors That Increase Susceptibility
| Risk Factor | Why It Matters |
|---|---|
| High steroid dose | Dose-dependent immunosuppression; >20 mg prednisolone/day significantly elevates risk |
| Long duration of use | Prolonged immune suppression allows cumulative colonization |
| Diabetes mellitus | High blood glucose feeds Candida; steroids worsen glycemic control |
| Inhaled steroid without spacer or mouth rinse | Steroid deposits in oral cavity directly suppressing local immunity |
| Concurrent antibiotic use | Antibiotics kill competing bacteria, enabling Candida overgrowth |
| Dentures or poor oral hygiene | Surfaces harbor Candida colonies |
Prevention Strategies
For Inhaled Corticosteroid Users
- Rinse and spit: Always rinse your mouth with water and spit after each dose. This removes residual steroid from oral mucosa.
- Use a spacer: Spacer devices reduce the amount of steroid deposited in the mouth and throat.
- Switch inhaler type: Dry powder inhalers may deposit more drug in the oropharynx than metered-dose inhalers with spacers.
- Brush teeth after use: Mechanical removal of residual particles reduces colonization opportunity.
Treatment of Steroid-Associated Yeast Infections
Oral thrush is typically treated with nystatin oral suspension (swish and swallow) or a short course of fluconazole. Vaginal candidiasis is treated with topical azole creams or a single oral fluconazole dose. Systemic candidiasis requires intravenous antifungal therapy (echinocandin or fluconazole) and carries significant morbidity.
If recurrent candidiasis occurs during steroid therapy, the prescribing physician should evaluate whether the steroid dose can be reduced, an alternative anti-inflammatory can be substituted, or prophylactic antifungal therapy is warranted.
Frequently Asked Questions
Topical corticosteroids applied to skin folds (groin, armpits, under breasts) can promote Candida skin infections (cutaneous candidiasis) by suppressing local immunity and creating a warm, moist environment. This is more common with potent fluorinated steroids under occlusive dressings.
Anabolic steroids (testosterone and its synthetic derivatives) are not glucocorticoids and do not suppress immunity the same way. They are not a known cause of candidal yeast infections. Injection site infections from non-sterile technique are a different concern.
Oral thrush can develop within days to weeks of initiating inhaled corticosteroids, particularly if mouth rinsing is not practiced. Discontinuing mouth hygiene during established treatment is a common trigger for recurrence.
Generally no—stopping steroids abruptly can be medically dangerous. Yeast infections are treatable. Consult your prescribing physician who can manage both the infection with antifungals and assess whether steroid dose adjustment is appropriate.
Yes. Asthma and COPD patients on inhaled corticosteroids are at higher baseline risk. Proper inhaler technique and consistent mouth rinsing are the primary preventive interventions.
